| Logo | Name | Σ | Employees |
|---|---|---|---|
|
Unlocking the access to innovative ingredients and APIs thanks to plant biotechnology. STH BIOTECH develops unique and reliable plant-biotech process to unlock the production of rare APIs and innovative botanical ingredients. 58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
20 | 1 |
|
Building the first generation of genetically enhanced plants for sustainable mining. We are Genomines. We genetically enhance metal hyperaccumulator plants to produce bio-sourced metals and limit the environmental impact of mining groups. We are hiring! Apply on Lever now: https://jobs.eu.lever.co/genomines Biotechnologies, Metals, Phytomining, and Phytoremediation 76 similar entities Type: Startup Activities: greentech cleantech Technologies: Decarbonization |
17 | 41 |
|
From hope to reality Young start-up that aims to revolutionize precision medicine by developing innovative and non-invasive diagnostic tests dedicated to monitoring patients with various pathologies. CGenetix is mainly focus on the development of its first diagnostic test dedicated to kidney graft monitoring in transplant patients. biologie moléculaire and Bio-informatique 56 similar entities Type: Startup Activities: deeptech biotech healthtech |
14 | 12 |
|
Specialized nutrition to reconcile health, pleasure and microbiota Carembouche creates Carembouchees, “pleasure and health” snacks for people who do not eat enough to cover their needs. Not eating enough leads to malnutrition, which has affected 2 million adults in France over the past 60 years. The elderly and adults treated for long-term illnesses are most at risk of malnutrition. Undernutrition increases the risk of dependence and mortality by a factor of 4. The Carembouchées are compatible with the constraints linked to age and disability. They are small, delicious, rich and practical. 42 similar entities Type: Startup Activities: foodtech |
27 | 5 |
|
CDMO expert specialized in gene delivery It is with deep regret that we announce the liquidation of FlashTherapeutics and the end of its activities. Over the years, FlashTherapeutics has been driven by the ambition to innovate and bring transformative solutions to patients. This journey would not have been possible without the dedication of our talented team, the trust of our partners and clients, and the unwavering support from all those who believed in our mission. We want to warmly thank all employees, collaborators, and stakeholders who contributed to this adventure. Your commitment, creativity, and passion have left a lasting mark. … 52 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology |
26 | 15 |
|
Make sustainable fashion accessible for everyone At EverDye, we are depolluting the textile industry by providing a greener, faster and energy-efficient dyeing process. No waste and an improved circularity with our recyclable and reusable dye. FashionTech, Chemistry, GreenTech, TechForGood, and Dyeing processes 98 similar entities Type: Startup Activities: cleantech fashtech greentech manufacturing Technologies: Decarbonization |
21 | 39 |
|
Acoustic Cell Processing Solution 🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use. 💡Today, we have achieved proof-of-concepts … 88 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology |
31 | 12 |
|
Making Business Sense The Centre for Economics and Business Research is one of the UK's leading economics consultancies. We use economics and econometrics, surveys, qualitative research, expert interviews, modelling and scenario planning to help our clients understand their environment, forecast changes in it, build robust strategies and persuade others. As a recognised independent forecasting house, our top-line predictions for the United Kingdom are published by the Treasury and used in the Bank of England’s quarterly inflation report. We are innovative and our approach is unashamedly quantitative; our advice is supported by thorough numerical analysis. We challenge conventional wisdom and have … 10 similar entities Type: SMB Activities: martech |
30 | 36 |
|
Politics - Economy - Business The new Economist, a weekly newspaper and media specialist in the analysis of political, economic, social and professional news, puts its editorial know-how at the service of its readers. Also discover the best of The Economist and the Financial Times, official partners of our editorial staff. Subscribe! Press - Media, Politics - Public Affairs, Marketing - Communication, HR - Management, Economy - Social, Internet - Social networks, Art of living, Financial Times (partnership), and The Economist (partnership) Type: Media |
64 | 48 |
|
Advice on financing innovation and Seed Investor SHARPSTONE has developed an original and innovative approach by combining a consulting offering, SHARPSTONE Advisory (financing innovation) and an investment offering, SHARPSTONE Capital (seed VC for technology startups). Concretely, SHARPSTONE Advisory is a decompartmentalized, financial and operational consulting firm, which can be summed up in 3 key words: #technologies, #finance, #business. But, it is also and above all, a team of passionate and enthusiastic entrepreneurs. Strategic and financial consulting, Economic performance improvement consulting, Restructuring consulting, and Non-dilutive financing Type: Incubators & VCs |
47 | 43 |
|
Our mission: to make our genetic and agronomic experiences available to the agro-industry by creating tools Anova-Plus is an innovative GENOPOLE-certified company, created in 2012. We improve plant health for better animal and human well-being and develop early diagnosis tools to better understand crop enemies and thus better combat them. Innovation in favor of sustainable, responsible and environmentally friendly agriculture is a fundamental point in our company’s approaches and projects. Our Flashdiag® and MULTIgene® kits allow precise characterization of pathogens and weeds in order to optimize the technical routes of agricultural production. Biotechnology, Plant pathology, Plant breeding, and Genetics 87 similar entities Type: Startup Activities: agritech biotech Technologies: Decarbonization |
2 | 5 |
|
#DigitalManagers4Impact Institut Mines-Télécom Business School is a major business school founded in 1979, internationally recognized and AACSB and AMBA accredited. It is the business school of the largest group of engineering schools in France: IMT. The school offers training ranging from bac + 3 (Bachelor, post-baccalaureate recruitment) to doctorate, including numerous bac +5 level programs, including its flagship program, the Grande Ecole Program (PGE). Looking to the future, the school strives to continually renew its programs to offer (future) students useful training in a changing world. The school shares its campus with the Télécom SudParis engineering school, recognized for its … Type: NGO, Think-tanks, Ed, & Culture Activities: edtech |
81 | 417 |
|
Data Science, Intelligence and Society 🎯 Créé en 2017 dans le cadre de la Stratégie Nationale pour l’Intelligence Artificielle, l’Institut DataIA est le pôle d’excellence en IA de l’Université Paris-Saclay. Il fédère 14 établissements d’enseignement supérieur et de recherche, dont CentraleSupélec et l’ENS Paris-Saclay, ainsi que des organismes nationaux et partenaires académiques. 🔬 L’Institut œuvre à structurer l’écosystème IA autour de la recherche, de la formation et de l’innovation, avec des actions phares comme le projet SaclAI-School, lauréat de l’appel Compétences et Métiers d’Avenir. Sciences des données, Intelligence Artificielle, SHS, IHM, Big Data, Droit, Deep learning, Sciences sociales, Théorie de … Type: Public Technologies: Data Analytics A.I. |
87 | 19 |
|
Science for health Created in 1964, the National Institute of Health and Medical Research (Inserm) is a public scientific and technological establishment, placed under the dual supervision of the Ministry of Higher Education and Research and the Ministry of Health. Its researchers aim to study all diseases, from the most frequent to the rarest, through their biological, medical and population health research work. Inserm, health researcher since 1964 With a 2013 budget of €927 million, Inserm supports nearly 300 laboratories spread across France. All of its 1,200 teams bring together nearly 15,000 researchers, engineers, technicians, managers, university hospitals, post-docs, etc. … Type: Public Activities: deeptech healthtech |
284 | 7,708 |
|
The hospital innovation magazine Newsmagazine of reference, Hospitalia has been deciphering hospital news for more than a decade. Recognized for his in-depth investigations, his colorful reports, and his interviews with opinion makers, professional representatives and confirmed experts, he candidly addresses the issues faced, on a daily basis, by all those who keep the hospital running. Particularly renowned for its section devoted to health IT, Hospitalia does not hesitate to shine its spotlight wherever current events require it – laundry, pharmacy, biology, hygiene, imaging, traceability, catering, comfort, logistics, etc., in order to highlight business issues as close as possible to those … Type: Media |
63 | 5 |
|
From March 15 to 18, 2027 at Eurexpo Lyon. The voice and solutions of the industry #GI27 Industry Voice and Solutions. From March 15 to 18, 2027 at Eurexpo Lyon. Robotics, Assembly assembly, Electronics, 3d additive manufacturing, Materials processing, Forging & Foundry, Materials, Measurement, Control, Vision, Plastics, Rubber, Composites, Robotics, Services & Development, Smart Tech, Environmental Solutions, Sheet Metal Work, Metal Shaping, Machining, and Region & Country Type: Event Activities: it services |
222 | 36 |
|
Serving innovative companies. France Innovation represents and promotes French innovative companies. France Innovation is a professional association which brings together private research and technological development providers, companies offering innovative products, processes or services and those involved in innovation consulting and support. R&D, Innovation, Technological solution, Engineering, Industry, Technology, CIR, CII, Valorization, Technology transfer, Research Tax Credit, and Innovation Tax Credit Type: NGO, Think-tanks, Ed, & Culture Activities: consulting |
144 | 6 |
|
Support IMT and its schools to train, innovate and undertake, encourage research and shed light on the future The Mines-Télécom Foundation supports the IMT (Institut Mines-Télécom) in its missions in training, innovation, research and foresight, at the heart of digital, industrial, energy and educational transformations. Resulting from the transformation of the Télécom Foundation created in 2008, recognized as a public utility since 2012, the Mines-Télécom Foundation contributes to the development and influence of IMT and its major engineering and management schools: Télécom ParisTech, Télécom SudParis, IMT Atlantique, Télécom Ecole de Management, IMT Lille Douai, Mines Ales, Mines Albi, Mines Saint-Etienne. … Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech |
129 | 18 |
|
SUPPORT * CARE * INNOVATE The Ellen Poidatz Foundation, created in 1919 and recognized as a public utility in 1922, manages 29 pediatric follow-up care and rehabilitation health establishments (welcoming children from a few months to 18 years), medico-social establishments welcoming children, adolescents and adults with disabilities (motor, visual or hearing blindness, psychological disorder, autism, etc.) and structures for young children, whether or not they have a disability or illness. chronic. The Foundation allows children who can do so to follow an education adapted to their needs and abilities. It develops research actions through its Research & Innovation. medico-social, disability, … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech |
21 | 343 |
|
Develop scientific excellence and promote the region’s innovative strength Evry-Sénart Sciences and Innovation (ESSI) is an association which brings together higher education and research stakeholders in the Greater Paris Sud conurbation. Its purpose is scientific animation and the development of cooperation in training, research and innovation as well as the visibility and attractiveness of the territory of Grand Paris Sud Seine-Essonne-Sénart in these areas. ESSI brings together the following research and higher education players: - National School of Computer Science for Industry and Business (ensIIE) - Genopole - Institut Mines-Télécom Business School - Télécom SudParis - Évry Paris-Saclay University - … Type: NGO, Think-tanks, Ed, & Culture Activities: edtech |
25 | 1 |
|
Paris-Saclay, shared innovation #InnovationPlayground The Paris-Saclay Public Development Establishment drives and coordinates the development of the scientific and technological center of the Saclay plateau, as well as its international economic influence. He is the developer of concerted development areas within the scope of the Operation of National Interest. Paris-Saclay is a major area of development and innovation which relies on: - Paris-Saclay University and the Paris Polytechnic Institute representing an exceptional scientific concentration in terms of its scale, its disciplinary diversity and its level of excellence; - A dynamic of innovation at work in several strategic sectors of activity serving … Type: Public Activities: smart city |
188 | 167 |
|
The Future of Science, Today In the face of the exponential growth of scientific data and the unprecedented opportunities offered by large-scale analysis, it has become essential to rethink how knowledge is accessed and how we interact with it. Today, the challenge is no longer the scarcity of information, but the ability to identify, analyze, and leverage it effectively. Emerit Science was founded on this conviction: 👉 to democratize access to scientific knowledge and to accelerate research and innovation on a global scale. To bring this vision to life, we develop AI-driven solutions built around scientific agents—designed to operate across … 60 similar entities Type: Startup Activities: it services deeptech Technologies: A.I. Data Analytics |
22 | 6 |
|
We provide seamless, global and reliable connectivity over air, land and sea via a new generation of SATCOM terminals. Planexus is a spin-off from CNRS and University of Rennes laboratory I.E.T.R. The company is launched in December 2022 by 4 passionates about SATCOM to supercharge the development of the lab’s promising new one-antenna terminal technology. Our executive co-founders bring a unique combination of scientific excellence and business skills to the company. Our scientific co-founders is made up of the world’s most accomplished experts in antennas and hyperfrequency devices. PLANEXUS aims to provide new generation user terminals that meet the challenges … 30 similar entities Type: Startup Activities: telecommunications it services |
13 | 5 |
|
Reveal the secrets of your pet's DNA! Reveal the secrets of your cat's DNA! We offer a comprehensive analysis of your feline family's inherited traits and diseases. 🐾 pet genetics 57 similar entities Type: Startup Activities: pettech healthtech |
2 | 3 |
|
First studio specializing in the design, production and promotion of healthy communities. MedShake Studio 👂✨ is the first French studio specializing in the design, production and distribution of podcasts in the health sector. The studio offers several original creations that talk about women's health, life in the hospital or chronic pathologies: Pathways, mentors, Health Experts, Endometriosis Mon Amour, Le Journal d'une Infirmière, MICI and co. Two of them received prizes! MedShake Studio also publishes the podcast-sante.com site which lists all podcasts in the health sector, to give them more visibility. Because producing beautiful podcasts is good, but producing podcasts that … 31 similar entities Type: Startup Activities: healthtech |
45 | 6 |
|
Innovative science to improve the health of patients To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation. 55 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
24 | 5 |
|
🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. [join.gourmey.com] GOURMEY is France's pioneering cultivated meat company. 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. > Join.gourmey.com 23 similar entities Type: Startup Activities: cleantech greentech Technologies: Decarbonization |
40 | 57 |
|
Delivering the promise of immunotherapy Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological insights from the millions of gut bacterial proteins in constant cross-talk with the human body. The company is currently developing a pipeline of drug candidates consisting of OncoMimicsTM peptide-based immunotherapies for the treatment of cancer. EO2463 is in a Phase 2 clinical trial for indolent non-Hodgkin lymphoma, demonstrating a benign … 113 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology |
16 | 31 |
|
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology 71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
46 | 128 |
|
Bringing expertise and agility to biotech companies Founded in 2013 and headquartered in Montpellier, France, INITS is a pharmaceutical development and biomanufacturing services company supporting biotech and life sciences companies developing new therapeutic products. With more than 13 years of experience and over 250 clients supported in France and internationally, INITS provides expertise across biologics (cell and gene therapies, extracellular vesicles, antibodies and proteins) as well as small and large molecules. Its team of more than 40 experts supports the full range of pharmaceutical development activities, including CMC development, Regulatory Affairs, Clinical Supply, Quality Assurance and GMP audits. INITS is … 64 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology |
33 | 49 |
|
Actor committed to therapeutic progress in the service of patients and French health sovereignty 2nd French pharmaceutical laboratory, Servier is an international and independent group governed by a foundation. This governance structure allows you to benefit from a long-term vision focused on innovation for the benefit of patients, integrating the patient's voice at each stage of the drug life cycle and the creation of value in France. World leader in the cardiovascular field and number 1 in the treatment of high blood pressure, the Group develops effective and innovative solutions that promote patient care and therapeutic adherence. Servier aims to … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech |
24 | 242 |
|
Digital, an accelerator of diversity In 2017, Mounira Hamdi and Anthony Babkine, specialists in consulting and digital communication, drew up an important observation: France is full of job seekers with an appetite for digital technology and talented entrepreneurs in the field of Tech & digital, they nevertheless note the absence of diversity in digital and Tech professions in France and internationally. Despite their determination, these talents or diversity Tech entrepreneurs face numerous obstacles (lack of information, support or guidance advice, etc.) Convinced that the diversity of profiles is an important lever for the performance of companies and the country, Mounira … Type: NGO, Think-tanks, Ed, & Culture Activities: hrtech |
141 | 37 |
|
Biotech Career Network | Empowering Life Scientists to Build Careers Beyond Academia | 25+ Years of Community Impact Réseau Biotechno is a national network uniting several young scientist associations across France. As a key player in career development for the life sciences, we have been empowering students and early-career professionals for 25+ years, helping them make informed decisions and transition successfully from academia to the private sector. Our core initiatives: 🔹 Biotechno Forums & Events – Our flagship annual conferences and other networking events in major French cities. Biotechno Forums serve as essential platforms for networking, knowledge exchange, and career … Type: NGO, Think-tanks, Ed, & Culture Activities: edtech |
14 | 40 |
|
AI-Powered Cytometry & Cell Metabolism Profiling At Metafora, we develop innovative and impactful AI-powered cytometry & cell metabolism profiling solutions. We are passionate about cell biology. We leverage our unique cell metabolism and AI-powered data analysis platforms to turn disruptive single-cell technologies into impactful solutions that improve human health. biomarkeurs, cell metabolism, flow cytometry, data analysis, biotechnology, IVD tests, diagnostics, diagnostic tests, cell biology, neurometabolic diseases, metabolic diseases, oncology, multiple myeloma, research, and AI 139 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
24 | 32 |
|
The innovation platform for digital life sciences and health Gencovery is transforming digital life sciences with ConstellabTM — the open, flexible AI and data platform designed for all stakeholders in the field. ConstellabTM connects, consolidates, and enhances data across the entire value chain — from R&D and testing to production, market launch, and real-world evidence. Key capabilities include: - Scalable computing infrastructure (cloud & on-premises) - Unified dashboards for project, team, and workflow management - Advanced data labs for AI, data harmonization, and knowledge discovery With ConstellabTM, life sciences companies can fully harness their data, accelerate innovation, and deliver better … 67 similar entities Type: Startup Activities: biotech deeptech it services Technologies: SaaS A.I. |
43 | 9 |
|
Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … 65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
18 | 84 |
|
Improving vaccines, diagnostics and medical devices with endotoxins expertise. LPS-BioSciences is an Innovative SME in Biotechnology, founded in November 2011. SAS with capital of €50,000. LPS-BioSciences offers human and animal health, cosmetics and agri-food companies analysis and extraction services for endotoxins (LPS), molecules present on the surface of bacteria and playing a major role in the immune reaction. The Company also carries out collaborative projects in the fields of bacterial detection (E. coli, Erwinia). The company's flagship project lies in the research of a new vaccine adjuvant, based on LPS, for which LPS-BioSciences received support from OSEO. Health, Cosmetics, Agri-Food, … 62 similar entities Type: Startup Activities: biotech healthtech agritech deeptech Technologies: Data Analytics |
4 | 8 |
|
THERANOVIR is a young innovative Health-Tech company of Research and Development of breakthrough therapies in 3 fields of closely related pathologies, Cancer, Obesity and associated metabolic diseases and Infectious Diseases by targeting a platform of signaling pathways regulated by the protein complex NRP-1/OBR, newly discovered by the CEO/CSO Dr. Zakia BELAID-SANDAL (PhD). THERANOVIR benefits from a global and exclusive license from INSERM transfert for the valuation of 2 families of granted patents in Europe, United States and Japan. THERANOVIR filed its own patent in January 2023. THERANOVIR is a winner of the Lab-SHAKER 2017 (Genopole), Onco-Entrepreneurs 2018 (Cancer Campus, Villejuif), … Type: Incubators & VCs |
11 | 3 |
|
Antibody for Therapy AbTx is a preclinical stage biotech company developing the next generation of oncology treatments to treat incurable cancers. AbTx platform is developing mAb innovative enzymatic conjugation. Our platform unlock New Frontiers in Medicine to overcome ADC major drawbacks associated targeting solid tumors by generating antibody Fragment Drug Conjugates (FDCs). ADC, Oncology, and drug develoment 83 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
14 | 8 |
|
hVIVO - Making Innovation Possible Venn Life Sciences is now hVIVO. Making Innovation Possible hVIVO plc (Ticker: HVO) is a science‐led early‐phase drug development company purpose‐built to meet the growing complexity of modern clinical research. The Company operates an integrated early‐phase ecosystem that combines specialist clinical sites, advanced virology and immunology laboratories, human challenge expertise, and early drug development consulting. This unified model enables sponsors to generate rigorous, decision‐ready human data earlier in development, reducing uncertainty and accelerating progression through Phase I and II trials. With industry‐leading capabilities in respiratory and infectious disease, alongside expanding expertise in cardiometabolic and other … 123 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
7 | 74 |
|
Federating research and medical innovation in oncology / Leading the community of researchers in Île-de-France Our missions: - Bring together skills and research resources in the field of cancer in Île-de-France - Strengthen the research-care continuum through a close association of clinical (bedside) and pre-clinical (laboratory) research - Develop industrial partnerships The Cancéropôle Île-de-France Public Interest Group brings together: 7 member institutions: Public Assistance-Hospitals of Paris, Curie Institute, Gustave Roussy Institute, University Institute of Hematology - Paris Diderot University, Jean Dausset Foundation - CEPH, Pierre and Marie Curie University, Pasteur Institute Partners: Ariis, Association for Research against Cancer, CEA, CNRS, … Type: Public Activities: deeptech healthtech biotech |
15 | 6 |
|
The Development Challenge. [CSR Committed Label confirmed level] Join a bank that is both locally anchored and forward-looking. At Caisse d'Epargne lle-de-France, your ideas and vision impact the region! Come write your story with us! Type: Large company |
60 | 3,925 |
|
The birth of the National Library of France is often associated with Charles V who set up his private library at the Louvre in 1368. But it was not sustained until the reign of Louis XI (1461-1483). It was strengthened in its collections with François I who established, through the Montpellier Ordinance of 1537, the legal deposit of printed matter, now generalized and all media, including the Web. The BnF today has 14 collections departments, distributed between the Richelieu, Tolbiac, Arsenal and Bibliothèque musée de l'Opéra sites. The BnF is also present in the region, notably through the Maison Jean-Vilar … Type: Public |
91 | 1,699 |
|
1st weekly specialist information, biotech, medtech, e-health, finance published by Jacques Bernard Taste PRESENTATION The weekly Biotech Finances letter approaches from an economic and financial angle all questions linked to the development of the biotechnology sector and more broadly life sciences. Our target readership is mainly made up of biotechnology companies focused on health and the development of new therapies and new disease treatments, pharmaceutical companies (big pharma and other laboratories), investors, business angels, investment funds, venture capital, specialized in the biotech sector, institutions, legal advisors, development experts, and service providers and equipment suppliers. Our articles deal with research and … Type: Media |
63 | 10 |
|
Let's build your real estate future ATLAND is a listed global player present across the entire real estate value chain. With more than €10 billion under management, ATLAND is involved in asset management and development operations. ATLAND is listed on Euronext in Paris, Compartment B (ISIN code: FR0013455482) Our brands Asset management: - ATLAND Neighbor -ATLAND Investment Management - REIM Keys -MyShareCompany -Aedgis - Fundimmo Development Operations - ATLAND Residential - ATLAND Enterprises - Marianne Houses Asset Management, Property Management, Residential Development, Investment, Renovation Enhancement, Corporate Real Estate, Asset Management, New Housing, Intergenerational Housing, and Real Estate Development Type: Incubators & VCs Activities: proptech |
38 | 202 |
|
For a France strong in its research ANRT is the public-private intersectoral network for French research. It offers its members the best conditions for exchange, debate and confrontation, to build a common strategic vision and develop a force for action. A trusted third party, its members entrust it with their unvarnished point of view, allowing objective analyses, well-founded proposals, and the guarantee of being listened to. Public decision-makers pay attention to our work and we report regularly to ministers and parliamentarians. We clearly display our ambition for impact. Our work is intended to participate in the challenges of organizational transformation … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech |
135 | 44 |
|
Green valorization of organic biomass through the extraction of Keratin. What is HKVOR? ✅ The extraction of high added value bio-inputs from bio-waste ✅ a biotechnology project for #organic waste harvesting ✅ hundreds of thousands of tonnes of waste collected per year in France: Sheep hair and wool ✅ keratin extraction: - 🧬 capillary & animal ✅ an #innovative and #unique extraction protocol: - 🧪100% chemically clean - ♻️ without harmful impact on our environment #Greentech ✅ Deployment in different markets: -🧴cosmetics -🌱agricultural market -🪴Biostimulants market - 🏥medical devices - 💊food supplements -🛠️bioplastics and biomaterials ✅ Harvesting our waste thanks … 81 similar entities Type: Startup Activities: greentech cleantech Technologies: Bio sourced materials |
24 | 8 |
|
Engineering a Sustainable Future We are a strain development company. We engineer purpose-built secondary genomes that facilitate the bio-production of high value chemicals and enzymes. Inline with the circular economy, we are currently establishing a biorefinery that uses second generation sustainable feedstocks for fermentations. Biotechnology, Genome Engineering, Synthetic Biology, pigments, and fermentation 134 similar entities Type: Startup Activities: cleantech deeptech greentech Technologies: Synthetic Biology |
13 | 2 |
|
Creator of BUDDY 🤖, the First AI Emotional Robot Blue Frog Robotics is a market leader in Social Robotics providing high value, #Robotsforgood, to the Elderly, Fragile Children, Education System (supplier of the French Government) and international Events or Hospitality focused businesses. Blue Frog Robotics is the developer of Buddy, the world's first AI Emotional Robot, that has captured the affection of tens of thousands of people around the world. Buddy is built on an open based platform (Android SDK) and was conceived with the premise that it will become indispensable for all members of a household, much like today’s … 53 similar entities Type: Startup Activities: kidtech silvertech deeptech Technologies: Robotics Affective Computing A.I. IoT Generative A.I. |
145 | 2 |
|
Floating Genes
Early cancer diagnosis in liquid biopsy by ultra-sensitive ctDNA sequencing. Early cancer detection from liquid biopsies |
10 | 1 |
|
Media on the digital transformation of businesses, committed to “Stronger Together” Since its creation in 2012, our media has been at the forefront of the acceleration digital technology known by private and public organizations at the heart of the economy French. Today, its role is to offer a unique perspective on our professional environments. in transformation. We give keys to anticipation to our readers, through original and in-depth analyses, as much as by monitoring current events. We are one facilitator for sharing experiences for decision-makers, in a framework of trust. Our beliefs: The era of artificial intelligence that we have … Type: Media |
264 | 33 |
|
Partner companies of your R&D The mission of AFSSI is to support and serve the development of human and animal health products. Founded in 2012, AFSSI represents service companies in preclinical R&D. With this unique sector in Europe, AFSSI responds to the global evolution of the pharmaceutical industry which entrusts the key stages of its R&D programs to expert companies like ours. The main field support for health innovation, AFSSI represents the leading R&D center in France, with 10,000 high-level jobs, 1 billion euros in turnover and 300 companies. Professional association, Sector development, Lobbying, Sector animation, Business, Service mapping, open … Type: NGO, Think-tanks, Ed, & Culture Activities: consulting |
43 | 7 |
|
The think tank for Biotechnologies and One Health in France The independent Think Tank for Biotechnologies and ONE HEALTH in France, Adebiotech brings together industrial and academic experts as well as representatives of national and regional public authorities. With the largest French transdisciplinary network in life sciences, Adebiotech promotes biotechnologies and their applications in France, Europe and internationally. Adebiotech's interventions can be carried out transversally in all fields of application of biotechnologies, human and animal health, environment, energy, agri-food, industrial processes and sectors by encouraging sustainable development through the reasoned use of living techniques. Think tank biotechnologies, scientific conferences and … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech |
37 | 8 |
|
Where PhDs and companies meet Attachée à la promotion du doctorat depuis sa création en 1980, l'Association Bernard Gregory (ABG) aide les docteurs à concevoir leur projet professionnel et se présenter aux recruteurs. Elle aide également les entreprises à recruter des docteurs. Research in France, Europe & International, Human Resources, Training, Recruiting, Career coaching, Ressources Humaines, Formation, Recrutement, Conseil carrière, Recherche, PhD, and Doctorat Type: NGO, Think-tanks, Ed, & Culture Activities: hrtech |
125 | 39 |
|
CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization 165 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 7 |
|
International PR group | Market communications for healthtech & deeptech 🚀 Andrew Lloyd & Associates is an international public relations consulting group for leading edge companies and organizations involved in emerging technologies. ALA has its own offices in the United Kingdom and France, as well as a network of collaborators, individuals and companies, throughout Europe and the US. ALA has been active across Europe since 1987 and has the experience and know-how to provide seamless and scalable services in one or many EU countries and the US Andrew Lloyd & Associates is active in technical, business, financial and scientific communication. … Type: Media |
91 | 7 |
|
Pour chaque vie, la science agit The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research with a network of 33 members worldwide. In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology, with research focusing on the biology of living systems. Among its areas of investigation are … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech |
145 | 4,718 |
|
Disrupting Healthcare - De-risking Innovation - Transforming Technologies BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech |
36 | 59 |
|
Expect more from innovation! Science for good. All those involved in innovation, research, science and economic development have come together, one more time, to cast a spotlight on the technological innovations and scientific achievements that are made here every day. Accounting for 40% of public research and private R&D undertaken in Ile-de-France, the Paris-Saclay innovation cluster is undoubtedly at the forefront of French innovation. Innovation, FoodTech, GreenTech , Mobilités, Santé-Biotech , and Technologies Numériques Type: Public Activities: deeptech it services |
111 | 1 |
|
Le lab' de l'attractivité du Grand Paris : faire du Grand Paris le pionnier et le leader des transitions. Paris-Île de France Capitale Économique (PCE) is the innovation lab for the attractiveness of Greater Paris. Founded in 1991 by the Paris Île-de-France Chamber of Commerce and Industry (CCI) alongside around thirty major French companies and supported by the Greater Paris Metropolis, PCE analyzes the trends and factors shaping today’s and tomorrow’s most attractive cities. PCE identifies key challenges and proposes concrete solutions to help Greater Paris and its stakeholders anticipate major transitions and assert their leadership on the global stage. … Type: NGO, Think-tanks, Ed, & Culture Activities: e-commerce |
171 | 14 |
|
We make the impossible sourcing of rare medicinal plants flawless If you are a meticulous brand seeking premium botanical ingredients, you are at the right place ! BOTALYS makes the sourcing of rare medicinal plants both possible & sustainable, allowing our clients to harness the full potential of biodiversity while preserving it. Our exclusive biomimetic farming technology allows us to grow our own medicinal plants under ideal wild-like conditions, resulting in active botanical ingredients of the highest standards. What is Biomimetic Farming Technology ? Using an indoor vertical farming approach, BOTALYS managed to reproduce & optimize wild-like growth conditions, by … 47 similar entities Type: Startup Activities: deeptech healthtech Technologies: Bio sourced materials |
16 | 27 |
|
Driving the future of sustainable nutrition with gourmet, healthy and natural mycelium-based foods🍄🥗 ✨ MYCFOODS: reinventing food with mycelium ✨ Thanks to its unique expertise in screening and its solid fermentation technology, MYCFOODS cultivates mycelium on a plant basis, to create Mynion®, a new generation of natural, gourmet and ultra-versatile foods. 🧪 Without extrusion, without ultra-processing, without artificial flavors or preservatives, our foods naturally reveal the best of the plant, with a generous texture, real nutritional richness and unprecedented culinary freedom, from starter to dessert 😋 🌍 A new food serving taste, health and the planet. ✨ MYCFOODS: Reinventing food … 62 similar entities Type: Startup Activities: greentech foodtech Technologies: Synthetic Biology |
47 | 5 |
|
Easy & Fast Enalees is a biotech specialized in the development and marketing of lyophilized molecular diagnostic tests for animal healthcare in Europe. Leader of PCR type veterinary tests, Enalees uses the technology named LAMP (Loop-mediated isothermal amplification) to diagnose infectious canine, feline, and equine diseases in a simple, rapid, and reliable fashion. Thanks to its expertise in lyophilization, Enalees also provides development opportunities for other companies in the health, agriculture, and environment sector. Relocating the creation and production of rapid molecular diagnostic tests in France has also become an ambition of the company. Enalees already demonstrated the proof of … 44 similar entities Type: Startup Activities: pettech biotech |
28 | 40 |
|
🧬The Future of Food Safety 🦠 🧬DNTech specialized in the detection of pathogens in the food industry, directly on the production line. In addition to a fast, reliable detection kit, we offer our expertise by supporting you from beginning to end. Opt for an integrated solution directly on the processing line, combining safety and simplicity, for effective quality controls and food audits. => Our commitments : - ⏱️ Detect pathogens faster, to minimize batch recalls - 🛠️ Provide accessible technology that requires NO quality control expertise. - 👥 Optimize quality control costs and resources, so you can focus on your … 16 similar entities Type: Startup Activities: greentech Technologies: Decarbonization |
20 | 4 |
|
New therapies for neurodegenerative diseases Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases that currently lack curative and/or disease-modifying treatments. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase III trial with positive topline results for the treatment of Charcot-Marie-Tooth disease type 1A (‘CMT1A’) and benefits from orphan drug status in Europe and the United States. An international pivotal Phase III study of PXT3003 in CMT1A, the PREMIER trial, is currently ongoing. PXT864 has generated encouraging Phase II results in Alzheimer’s disease and will be advanced through partnerships. Both of Pharnext’s … 63 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
5 | 19 |
|
Investing responsibly for the future. With €500 million of assets under management and a portfolio of over 160 SMEs, M Capital Partners is a leading Private Equity firm in the French Small-cap market. Since 2015, M Capital is actively growing its venture portfolio (Seed – Series A and B) and has just launched a venture fund alongside FEI (European Investment Fund) and Occitanie region. In 2018, our affiliated companies employed over 11200 people and generated more than €2 billion in turnover. M Capital Partners has offices in Paris, Toulouse, Bordeaux, Nice, and Lyon. We have built a team of 40 … Type: Incubators & VCs |
67 | 59 |
|
Created in 1907 CCI France International brings together and animates the 120 French Chambers of Commerce and Industry Abroad (FCCIA), present in 90 countries. French Chambers of Commerce and Industry Abroad support companies in their international development. They offer a wide range of services, adapted to each step of the company's project. FCCIAs animate the French business community abroad thanks to more than 4,300 events each year: conferences, seminars, workshops, trainings, exhibitions, committees ... The 120 FCCIAs are managed by more than 1,100 permanent employees, mostly bicultural. Nearly 35,000 companies are members of our international network, making it the leading … Type: NGO, Think-tanks, Ed, & Culture Activities: e-commerce |
122 | 54 |
|
The Biotherapy Network MabDesign is a leading organization driving the growth, competitiveness, and global visibility of the biotherapy industry. As a membership‐driven network, we connect companies, experts, and partners across the biotherapy value chain to build a robust and innovative industrial ecosystem. Based in Lyon one of Europe’s major life‐science hubs we operate at the intersection of scientific excellence, industrial knowhow, and strategic collaboration. Our team is composed of highly qualified specialists, most holding PhDs in fields directly related to biotherapy and bioproduction. This advanced scientific expertise, combined with hands-on industry experience, enables us to deliver rigorous, impactful support to … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech |
62 | 30 |
|
Ecole d'ingénieurs interculturelle Icam, an education company Above and beyond scientific education, we aim to encourage personal development. Our institutions are organized on a human scale, allowing students to enjoy the benefits of individual coaching and working in small groups. Our full-time teaching staff ensures the role of coaching students and supporting them throughout their projects. Graduate engineers can benefit from a highly active alumni network, which allows them to maintain relations with their institute and provides them with support throughout their careers. The partnership with Jesuites ICAM is over 100 years old and was founded by the Jesuit order. … Type: NGO, Think-tanks, Ed, & Culture Activities: edtech |
85 | 1,314 |
|
Biomanufacturing, development & analytical services: Plasmids, Antibodies, Recombinant proteins, Cells - FastELISA kits French CRO Biotechnology 🔎 BIOMANUFACTURING: Plasmids (R&D and High Quality grades, And Now a pDNA GMP unit), Monoclonal antibodies, Recombinant antibodies (scFV, Fab, bispecific...), recombinant proteins (E.Coli, Cell free system, Yeast and mammalian cells), cells. 💡 Antibody engineering & molecular biology platforms: Antibody sequencing, vector design & cloning, Recombinant antibody production, Chimerization and Humanization, cell line development... ✍ Analytical services: immunoassays development, antibody characterisation, quality controls (R&D and high quality grades) FastELISA kits: Immunoglobulin quantification (human, mouse, rat, bovine), Mouse Immunoglobulin isotyping, Contaminant detection (Protein A), other … 75 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
16 | 71 |
|
Karista is a European VC firm investing in game changers from scratch to success. Karista is an early-growth investment firm backing ambitious entrepreneurs across Europe. For nearly 25 years, we have supported over 100 startups and scale-ups, many of which have achieved successful exits through acquisitions or listings on major exchanges, including Nasdaq. Our current strategy focuses on two key sectors: HealthTech and Space, Defence & Security, executed through dedicated funds and specialized teams with deep domain expertise. We primarily invest in early-growth opportunities, while selectively supporting early-stage moonshot projects with transformative potential. Trusted by leading institutional investors, financial groups, … Type: Incubators & VCs |
14 | 19 |
|
The leading European Business Angels network in healthcare investment Europe’s number one Business Angel Network for Health Angles Santé investors provide their funds and expertise to start-ups with strong potential to support their launch and development. Our mission at Angels Santé: to detect European start-ups that meet the challenges of our health systems with economically responsible solutions and strong medical benefits, to boost seed-stage development by providing direct capital, expertise and networks, to mobilize non-specialized investors towards health investment to meet the needs of ambitious projects. Our members invest in healthcare projects that they understand, thanks to their expertise and … Type: Incubators & VCs |
92 | 70 |
|
The leading xAI-driven drug development company Ariana Pharma is a leading Artificial Intelligence (AI) drug development company. Using its KEM® Artificial Intelligence (xAI) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and optimize clinical endpoints, identify biomarkers of therapeutic response and potential synergistic therapies. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as Fluorescence-Activated Cell Sorting (FACS)), microbiota, Patient Reported Outcomes (PRO) as well as Real World Evidence (RWE) data. Combining advanced data analytics, drug development, and regulatory expertise, Ariana helps translate findings into innovative clinical development plans and … 62 similar entities Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics |
16 | 32 |
|
Obsessed Visionaries Navigating Impossibilities. 1st-check VC firm committed to entrepreneurs redefining global markets OVNI Capital is a first-check venture capital firm committed to aliens redefining global markets. With offices in Paris and San Francisco, we partner with entrepreneurs seeking to invent new markets or disrupt large existing industries, with a crucial focus on early internationalization. We only invest if a company has the potential to be a global market leader with a strong impact on human lives. We favor being the first venture investor and we follow on our investments. We invest as little as €250k to seed a company … Type: Incubators & VCs |
30 | 34 |
|
BioCytex is a contract research organization specializing in biomarker detection and analysis of normal and pathological cells in whole blood, bone marrow and other tissue samples. With over 20 years of experience in flow cytometry, we have a wide range of experience in developing and validating assays to suit many different requirements including immunophenotyping, detection of intracellular / extracellular markers, antigen binding assays. With the capacity to simultaneously measure multiple parameters on hundreds of individual cells per second, flow cytometry is a powerful technology with a wide variety of applications in pharmaceutical development. BioCytex is working with worldwide pharmaceutical companies. … 74 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology |
15 | 19 |
|
Explore and share The Fondation Tara Océan, first recognized public interest foundation in France dedicated to the world's oceans, is leading a scientific revolution: the Foundation has developed an open, innovative Ocean science that will enable us to predict, anticipate and better manage tomorrow's climate risks. We use high-level scientific expertise to raise awareness and educate young people, mobilize policy makers at the highest level, and enable emerging and developing countries to access the latest knowledge about the Ocean. A true floating laboratory, Tara, the research schooner, has already traveled more than 375,000 kilometers, making stopovers in more than 60 … Type: NGO, Think-tanks, Ed, & Culture Activities: it services |
69 | 96 |
|
Research PIECES
3D-living systems to model life Research PIECES is a Deeptech Startup of Biotechnology based on the campus of the University of Poitiers, Southwest of France. The goals of the startup are to understand the physiology & the physiopathology of the Central Nervous System (CNS) through Research, Development & Treatment. For that Research PIECES proposes preclinical biological & innovative models to dissect molecular, cellular and tissular mechanisms in a physiological 3D-living tissue environment. One of our main mission is to propose preclinical innovative models to find the future therapeutic molecules against neurological diseases (neurodegenerative diseases, cancer, infectious diseases, etc.). Our models … 77 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
24 | N/A |
|
As a food-tech company, Algama harvests the potential of algae to create food that's good for both people and the planet TAMALGA® SE SUBSTITUE AUX OEUFS. Première gamme à base de micro-algues, performante et accessible destinée aux artisans et à l’industrie de la boulangerie pâtisserie. Microalgae, FutureofFood, algae, plant based foods, ingredients, vegan foods, egg replacer, dairy alternatives, and seafoods alternatives 127 similar entities Type: Startup Activities: cleantech foodtech greentech Technologies: Decarbonization |
69 | 34 |
|
carbon conscious color company Pili, carbon conscious color company Pili is the leader in bio-based colorants and pigments. Its unique fermentation and sustainable chemistry processes, enable the production of high-performance, and low-carbon colors. Its technology aims at decarbonizing the color industry by drastically reducing the use of chemicals and fossil resources, particularly oil. Its products are designed for the textile, inks, paints & coatings and plastics sectors. Founded in 2015, Pili operates from 3 different sites: Toulouse White Biotechnology (TWB), Paris and the Roches-Roussillon industrial platform in Isère. Biotechnology, Bioproduction, Biomaterials, Dyes, Textile, Inks, Organic chemistry , Pigments , Paints … Type: Startup Activities: biotech manufacturing deeptech Technologies: Bio sourced materials Synthetic Biology |
31 | 76 |
|
Synsight activity is now integrated into @iktos https://iktos.ai/ https://www.linkedin.com/company/iktos/ Synsight was a company created in 2013, by two co-founders PhD Computer aided drug design: Cyril Bauvais (CEO) and Guillaume Bollot (CSO). In july 2024, Synsight was acquired by @iktos, an AI drug discovery company. Its tech is based on AI drug design and cell imaging, including a proprietary cell based assay named MTBench, to profile compounds modulators of protein-protein and protein-RNA interactions, and protein agregation. criblage virtuel, modélisation moléculaire, dynamique moléculaire, QSAR, drug design, chémoinformatique, and drug discovery 59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
12 | 1 |
|
Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi operates multiple manufacturing suites for bulk drug substances (up to 1,000 L) and fill and finish to support the growing demand for late-phase projects. In 2023, Yposkesi will bring online … 57 similar entities Type: Media SMB Activities: deeptech biotech Technologies: Synthetic Biology |
24 | 130 |
|
1st national Cyclo-logistics operator 🚴🏻❤️ All your pollution-free deliveries with Vlove® Cyclo-logistique! By bike, cargo bike, tricycle or electric scooter; our Riders ride for you in the streets of Paris, Lille, Lyon, Bordeaux, Nantes, Toulouse, Aix en Provence, Grenoble, Marseille, Montpellier and Annecy 🚴🏻❤️ Our mission? Making tailor-made ecological delivery accessible! Vlove® Cyclo-logistique is a delivery company committed to more sustainable and responsible logistics. This environmental commitment is accompanied by a plan aimed at combating the precariousness of the courier/delivery profession. Circulating in uniform or in your colors, behind the wheel of fast, agile and non-polluting vehicles, your Rider actively … 83 similar entities Type: Startup Activities: transporttech Technologies: Decarbonization |
3 | 13 |
|
A versatile immunotherapy for personalized cancer medicine Inovactis is developing an innovative treatment against cancer on the border between several ongoing revolutions: individualized medicine, immunotherapy and synthetic biology. immunotherapy and personalized medicine 59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
1 | 1 |
|
From preclinical hope To clinical proof, without the guesswork. Scienta is a deeptech company advancing translational research in immunology. Scienta develops EVA, the first AI foundation model purpose-built for translational prediction in immune-mediated diseases. EVA addresses a critical challenge in pharma R&D: the preclinical–clinical gap, where fewer than 10% of immune drug programs translate successfully to humans. Built on more than 3 billion multimodal data points across 30 diseases and 70 tissues, EVA uses a biology-first architecture designed to reason like an immunologist. It converts early experimental signals into predicted patient outcomes, with explainable outputs such as pathway-level activity and … 61 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. |
29 | 16 |
|
1st secure platform for teleexpertise and collaborative eDiagnostics for healthcare practitioners and establishments. Rofim is a telemedicine platform connecting healthcare professionals in hospitals and in the city, facilitating diagnosis and improving patient care. It is based around teleexpertise, teleconsultation, assisted teleconsultation, e-RCP, oral and dental teleexpertise and Communicating Cancerology File. Bringing together 1,800 establishments and more than 80,000 doctors, Rofim has exceeded 2 million annual procedures in 2025. Created by doctors for doctors, the Rofim solution is supported by a committee of 40 healthcare professionals. A Mission-driven company since 2023, Rofim has this purpose at the heart of its strategy: … 57 similar entities Type: Startup Activities: healthtech Technologies: SaaS |
105 | 61 |
|
Bringing taste and diversity to the next generation of cheese and dairy. Bringing taste and diversity to the next generation of cheese and dairy. Join our team - find our job board here https://shorturl.at/nopIM 51 similar entities Type: Startup Activities: foodtech |
46 | 20 |
|
Unleash the Potential of Genomic Medicine Using AI WhiteLab Genomics is a TechBio company dedicated to unleashing the full power of genomic medicine with Artificial Intelligence. Founded in 2019 and backed by Y Combinator and the French Tech 2030 program, WhiteLab operates at the intersection of AI, computational biology, and structural biology, with offices in Paris, Boston, and Montréal. WhiteLab’s proprietary AI platform enables the rational design and optimization of delivery systems including viral and non-viral vectors, as well as RNA and DNA payloads. The company supports partners across a wide range of therapeutic areas, including but not limited to … 56 similar entities Type: Startup Activities: deeptech it services Technologies: A.I. A.I. - Machine Learning Synthetic Biology |
97 | 56 |
|
Protein science inspired by nature At the forefront of the food and environmental transition, Standing Ovation is a French protein company pioneering advanced fermentation through cutting-edge precision fermentation technologies. The company has developed its first patented ingredient, Advanced Casein (tm) , which is produced with 4 times less CO2, and significantly less water consumption and land use than regular casein, while offering nutritional, functional and taste qualities on par with the animal-sourced protein. As a winner of the French Tech 2030 program, Standing Ovation has received government backing and support from leading shareholders for its industrialization, and signed a strategic … 51 similar entities Type: Startup Activities: foodtech manufacturing Technologies: Synthetic Biology |
50 | 56 |
|
Building resilient crops through next-generation plant engineering technologies. Resilient plants are at the heart of our fight against climate change. Plantik develops technologies to create resilient plants that survive today’s challenges, for a better tomorrow. 45 similar entities Type: Startup Activities: deeptech Technologies: Decarbonization |
5 | 11 |
|
Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a … 66 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology |
57 | 137 |
|
We strengthen the regional and local dimension in EU research and innovation policy and programmes. ERRIN is a well-established Brussels-based platform of around 120 regional stakeholder organisations from 22 European countries, most of whom are represented by its Brussels offices. We focus solely on research and innovation policy and funding programmes, as well as project development. Our members are mainly regional authorities, universities, research organisations, chambers of commerce, and clusters. They develop the agenda and the priorities of the whole network by taking an active role within our working groups or in our Management Board. Through our 13 working groups, … 29 similar entities Tags: H2020 Type: SMB Activities: deeptech Technologies: Decarbonization |
39 | 31 |
|
Type: SMB Activities: it services |
46 | 152 |
|
No one leaves Suresnes who often does not return there SURESNES, AN INNOVATIVE AND SUSTAINABLE CITY Located on the outskirts of Paris, on the edge of the Bois de Boulogne, Suresnes is a dynamic town in the west of Paris which extends from Mont-Valérien, a place steeped in history, to the banks of the Seine. From "the Garden City", a model of social urban planning built between the wars, to the recent eco-exemplary district, "Ilot Sisley", its 49,000 inhabitants bring the six districts that make up the City to life harmoniously. A wine-growing village in the Middle Ages, Suresnes still … Type: Public |
100 | 368 |
|
Association œuvrant pour le développement du secteur des protéines végétales et des nouvelles ressources Protéines France is the French consortium of enterprises whose ambition is to federate and catalyse the development of innovative. Protéines France aims to speed up the development of the plant-based and alternative protein sector in order to seize the opportunities for growth and job creation offered by the global increase in the demand for proteins and thus to make France a world protein leader. PROTEINES FRANCE *We focus on innovative proteins: plant-based and alternative sources (insects, algae, microorganisms...) *We bring together the major French innovative proteins … Type: NGO, Think-tanks, Ed, & Culture Activities: agritech |
52 | 1 |
|
Measure what matters POLYTEC is a designer, developer and distributor of innovative optical measurement solutions for Research and Industry. Founded in 1967, the POLYTEC group is today made up of more than 400 enthusiasts around the world, with R&D and production headquarters in Germany and its subsidiaries in France, England, the United States, Japan, China, India and Singapore. 📢 Our main technological areas: • Laser vibrometry • Laser velocimetry • Optical profilometry • 3D scanner • Online spectrometry & portable • Optical infrared detectors • Fiber optic temperature controllers, • Xenon UV decontamination solutions • Machine Vision: lighting & industrial … 48 similar entities Type: SMB Activities: industry 4.0 Technologies: SaaS |
13 | 389 |
|
Working together to better nourish and protect the planet A key global player in fermentation for more than a century, Lesaffre, with a €3,2 billion turnover, and established on all continents, counts 11,700 employees and 100 nationalities. On the strength of this experience and diversity, we work with customers, partners, and researchers to find ever more relevant answers to the needs of food, health, naturalness and respect for our environment. Thus, every day, we explore and reveal the infinite potential of microorganisms. To nourish 9 billion people, in a healthy way, in 2050 by making the most of our planet’s … Type: Large company |
38 | 5,406 |
|
Productive and innovative territory The Grand-Orly Seine Bièvre Public Territorial Establishment is one of the 12 Territories of the Greater Paris Metropolis, created on January 1, 2016. It carries out public service missions and employs around 1,700 agents. Its administrative headquarters has been established since December 1, 2018 in Coeur d'Orly, in the immediate vicinity of the airport. Extended over the two departments of Val-de-Marne and Essonne, it brings together 24 municipalities in the form of a "city cooperative": Ablon-sur-Seine, Arcueil, Athis-Mons, Cachan, Chevilly-Larue, Choisy-le-Roi, Fresnes, Gentilly, Ivry-sur-Seine, Juvisy-sur-Orge, Le Kremlin-Bicêtre, L'Haÿ-les-Roses, Morangis, Orly, Paray-Vieille-Poste, Rungis, Savigny-sur-Orge, Thiais, Valenton, Villejuif, … Type: Public Activities: smart city greentech |
103 | 564 |
|
Biology x AI-powered drug development platform to transform precision oncology. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. 59 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics |
43 | 44 |
|
Let’s cultivate the light of tomorrow! Since its founding in January 2016, Woodlight has been a research and development startup for new biotechnologies. Its objective is to make cities greener by responding to their problems of pollution, lack of greenery and high energy consumption. To meet the growing needs for sustainable lighting and energy saving in cities, Woodlight proposes to develop a process to make plants bioluminescent. These plants can be used as mood lamps for interior decoration. We can then imagine an ivy, a ficus or even a luminescent orchid. Beyond these uses, these plants could be used as … 54 similar entities Type: Startup Activities: cleantech biotech deeptech greentech Technologies: Decarbonization |
48 | 7 |
|
The glyco design company Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved. Bioproduction and Cell … 84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology |
14 | 12 |